The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...
What is Dupixent for COPD? Dupixent (dupilumab) is an injectable therapy approved for adults with poorly controlled chronic obstructive pulmonary disease (COPD) and high counts in the bloodstream of a ...
The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...
Though I attempted to follow my treatment plan and watched for signs of an impending exacerbation, one crept up on me this summer and caused a worsening of my dyspnea, or the shortness of breath that ...
Caroline Gainer is from West Virginia, the state with the highest rate of COPD in the United States. She was diagnosed with moderate-to-severe COPD in 2013 after a pneumothorax (lung collapse). After ...
COVID-19, short for coronavirus disease 2019, is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly identified and highly contagious pathogen not previously ...
Common symptoms of chronic obstructive pulmonary disease, or COPD, include shortness of breath, a frequent cough or cough that produces a lot of mucus, wheezing, and tightness in the chest. Excess ...
The combination of glycopyrrolate and indacaterol (brand name, Utibron Neohaler; Novartis) is a long-term maintenance treatment of airflow obstruction or to prevent bronchospasm in people with COPD.